These resources are available to offer greater detail on the benefits of RELiZORB, and how it mimics pancreatic lipase function to deliver absorbable fats to enterally fed patients.

In these videos, a team of clinical experts explore issues associated with fat malabsorption and how RELiZORB may help address these challenges in patients who require enteral feeding.

Challenging Cases in Enterally Fed Patients
Challenges of Fat Malabsorption in Enterally Fed ICU Patients
Hydrolyze Fats
Fat Malabsorption in Enterally Fed Patients
Fat Malabsorption in Enterally Fed Patients: Challenging Cases in Patients with End Stage Lung Disease
In-Service for Inpatient RELiZORB Use

For more information on how to order RELiZORB, contact RELiZORB Support Services at 1-844-632-9271.


This information is intended for
US healthcare professionals


You are now leaving the RELiZORB
product website to view the
Alcresta Therapeutics corporate website.